LABU Could Rip Higher if Biotech Finally Gets Its Long-Awaited Breakout
Source ↗
👁 0
💬 0
The post LABU Could Rip Higher if Biotech Finally Gets Its Long-Awaited Breakout appeared first on 24/7 Wall St..
Quick Read
Direxion Daily S&P Biotech Bull 3X Shares (LABU) delivered 235% returns over the past year versus 65% for the underlying XBI biotech ETF by leveraging daily gains, but the fund is down 87% over five years as volatility decay and choppy trading patterns erode leveraged gains even
Quick Read
Direxion Daily S&P Biotech Bull 3X Shares (LABU) delivered 235% returns over the past year versus 65% for the underlying XBI biotech ETF by leveraging daily gains, but the fund is down 87% over five years as volatility decay and choppy trading patterns erode leveraged gains even
Comments (0)